Answers are grounded in this paper and cite their sources.
To investigate depressive symptom transitions and estimate total and state-specific life expectancy among older adults with arthritis, examining differences by sex and education. Data from adults aged 60–100 years with self-reported arthritis in CHARLS (2011–2020; n = 3,688) and HRS (2010–2018; n = 9,431) were analyzed using continuous-time multi-state Markov models. Four states were defined: no depressive symptoms, mild depressive symptoms, moderate-to-severe depressive symptoms, and death. Multi-state life tables estimated life expectancy (LE) and depression-free life expectancy (DFLE) at age 60 by initial depressive symptom state. Subgroup and sensitivity analyses were conducted. In CHARLS, LE at age 60 was 19.89, 19.85, and 19.48 years for individuals initially without depressive symptoms, with mild depressive symptoms, and with moderate-to-severe depressive symptoms, respectively; corresponding DFLE values were 11.65, 9.84, and 8.76 years. Similar patterns were observed in HRS, with LE estimates of 21.58, 20.65, and 19.88 years and DFLE estimates of 14.72, 12.00, and 10.25 years, respectively. Greater initial depressive symptom severity was associated with shorter DFLE and more years spent in moderate-to-severe depressive symptoms. Women had longer LE but a lower proportion of DFLE, while higher educational attainment was associated with longer LE and DFLE. Sensitivity analyses showed consistent patterns. Greater initial depressive symptom severity was associated with a more pronounced reduction in DFLE than in total LE among older adults with arthritis. These findings highlight the importance of monitoring depressive symptoms in long-term arthritis management, particularly among women and individuals with lower educational attainment. Not applicable.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: